Cardiovascular and renal risk reduction in  type 2 diabetes---which choice?

Type 2 diabetes mellitus is a major risk factor for both cardiovascular and kidney disease, with a shorter life expectancy than in people without diabetes. Until the last decade, the main therapeutic focus was on management of hyperglycemia, although the correction of associated abnormalities such as dyslipidemia, hypertension, hypercoagulability, obesity, and insulin resistance, were important secondary therapeutic goals.1 Close glycemic control was shown to exert beneficial effects on diabetes-specific microvascular complications, including retinopathy, nephropathy, and neuropathy.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Controversies in Nephrology Source Type: research